Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high‐risk cohort of men with negative initial prostate biopsies
- 11 November 2011
- journal article
- Published by Wiley in BJU International
- Vol. 110 (1), 56-62
- https://doi.org/10.1111/j.1464-410x.2011.10718.x
Abstract
Study Type – Diagnostic (exploratory cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Hypermethylation of genes such as glutathione-S-transferase P1 (GSTP1) and adenomatous polyposis coli (APC) occurs with high frequency in prostate tumour tissue but is much less common in the benign prostate; however, the potential value of gene methylation biomarkers as an adjunct to biopsy histopathology has had little study. When measured in histologically benign prostate biopsy tissue, APC gene hypermethylation was found to have high negative predictive value and high sensitivity. GSTP1 hypermethylation was found to have lower performance than APC. OBJECTIVE • To evaluate the performance of DNA methylation biomarkers in the setting of repeat biopsy in men with an initially negative prostate biopsy but a high index of suspicion for missed prostate cancer. PATIENTS AND METHODS • We prospectively evaluated 86 men with an initial histologically negative prostate biopsy and high-risk features. • All men underwent repeat 12-core ultrasonography-guided biopsy. • DNA methylation of glutathione-S-transferase P1 (GSTP1) and adenomatous polyposis coli (APC) was determined using tissue from the initially negative biopsy and compared with histology of the repeat biopsy. • The primary outcome was the relative negative predictive value (NPV) of APC compared with GSTP1, and its 95% confidence interval (CI). RESULTS • On repeat biopsy, 21/86 (24%) men had prostate cancer. • APC and GSTP1 methylation ratios below the threshold (predicting no cancer) produced a NPV of 0.96 and 0.80, respectively. The relative NPV was 1.2 (95% CI: 1.06–1.36), indicating APC has significantly higher NPV. • Methylation ratios above the threshold yielded a sensitivity of 0.95 for APC and 0.43 for GSTP1. • Combining both methylation markers produced a performance similar to that of APC alone. • APC methylation patterns were consistent with a possible field effect or occurrence early in carcinogenesis. CONCLUSIONS • APC methylation provided a very high NPV with a low percentage of false-negatives, in the first prospective study to evaluate performance of DNA methylation markers in a clinical cohort of men undergoing repeat biopsy. • The potential of APC methylation to reduce unnecessary repeat biopsies warrants validation in a larger prospective cohort.Keywords
This publication has 33 references indexed in Scilit:
- Identification of Differentially Methylated Genes in Normal Prostate Tissues from African American and Caucasian MenClinical Cancer Research, 2010
- The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free‐to‐total prostate‐specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?BJU International, 2010
- Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive BiopsiesCancer Epidemiology, Biomarkers & Prevention, 2009
- PSA Doubling Time as a Predictive Factor on Repeat Biopsy for Detection of Prostate CancerJapanese Journal of Clinical Oncology, 2009
- Quantitative, spatial resolution of the epigenetic field effect in prostate cancerThe Prostate, 2007
- Significance of Atypical and Suspicious Small Acinar Proliferations, and High Grade Prostatic Intraepithelial Neoplasia on Prostate Biopsy: Implications for Cancer Detection and Biopsy StrategyJournal of Urology, 2006
- The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic CurveAmerican Journal of Epidemiology, 2006
- PREDICTORS OF SUBSEQUENT PROSTATE CANCER IN MEN WITH A PROSTATE SPECIFIC ANTIGEN OF 2.6 TO 4.0 NG/ML AND AN INITIALLY NEGATIVE BIOPSYJournal of Urology, 2005
- Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10 ng/ml: Systematic Review and Meta-AnalysisEuropean Urology, 2005
- EXTENSIVE BIOPSY PROTOCOL IMPROVES THE DETECTION RATE OF PROSTATE CANCERJournal of Urology, 2000